We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current CLSN market cap is 18.42M. The company's latest EPS is USD -2.0763 and P/E is -0.41.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -5.48M | -3.9M | -5.97M | -5.01M | -5.01M |
Net Income | -5.56M | -3.48M | -4.89M | -4.93M | -4.79M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 500k | 500k | 502k | 500k | 0 |
Operating Income | -20.57M | -20.86M | -22.98M | -38.29M | -21.03M |
Net Income | -16.85M | -21.48M | -20.77M | -35.9M | -19.52M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 28.72M | 24.65M | 21.92M | 14.33M | 9.69M |
Total Liabilities | 7.21M | 6.58M | 8.53M | 5.83M | 5.95M |
Total Equity | 21.52M | 18.07M | 13.39M | 8.5M | 3.74M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 38.28M | 37.53M | 74.05M | 43.98M | 21.92M |
Total Liabilities | 23.72M | 18.92M | 18.25M | 14.65M | 8.53M |
Total Equity | 14.56M | 18.61M | 55.8M | 29.33M | 13.39M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -10.78M | -15.25M | -19.02M | -5.87M | -10.38M |
Investing | 3.64M | 14.31M | 11.01M | 2.38M | 9.85M |
Financing | -3.75M | -3.67M | -3.64M | N/A | N/A |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -20.26M | -15.62M | -16.22M | -23.13M | -19.02M |
Investing | 5.94M | 7.92M | -30.12M | 8.32M | 11.01M |
Financing | 7.84M | 17.98M | 54.77M | 6.72M | -3.64M |
Market Cap | 18.42M |
Price to Earnings Ratio | -0.41 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 1.37 |
Price to Book Ratio | 0.6 |
Dividend Yield | - |
Shares Outstanding | 9.4M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.1 (4.85%) |
Company Name | Celsion Corporation |
Address |
874 walker rd ste c dover, delaware 19904 |
Website | https://www.imunon.com |
Industry | health care diversified (H) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions